SURVEY SHOWS LUNG CANCER PATIENTS BLAMED FOR THEIR DIAGNOSIS
As public support decreases, so do research dollars and patient hope
As public support decreases, so do research dollars and patient hope
Washington, DC, November 12, 2008 – Survey results released today show that the general population blames lung cancer patients for their diagnosis, confirming the stigma that patients reportedly feel. Findings also demonstrate a lack of public support for patients and a need for greater research for the number one cancer killer. Conducted by Lung Cancer Alliance and AstraZeneca, LP (NYSE: AZN), the national survey assessed the views of lung cancer patients, oncologists and the general public on lung cancer, support for lung cancer organizations, research funding for the disease, and availability of appropriate treatment options.
“This survey reinforces what the lung cancer community has felt for decades – public perception of this disease is overwhelmingly negative,” said Laurie Fenton Ambrose, President and CEO of Lung Cancer Alliance. “We’ve got to do more to overcome this pervasive stigma and focus attention where it should be -- on research for early detection and treatment for lung cancer.”
“This survey reinforces what the lung cancer community has felt for decades – public perception of this disease is overwhelmingly negative,” said Laurie Fenton Ambrose, President and CEO of Lung Cancer Alliance. “We’ve got to do more to overcome this pervasive stigma and focus attention where it should be -- on research for early detection and treatment for lung cancer.”
No comments:
Post a Comment